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Abstract 
A low concentration of boron (B) accelerates the proliferation and 
differentiation of mammalian osteoblasts.  The aim of this study was to 
investigate the effects of 0.1 mM of B on the membrane function of 
osteoblastic cells in vitro .  Genes involved in cell  activity were investigated 
using gene expression microarray analyses. The Ca2 + influx and efflux were 
evaluated to demonstrate the activation of L-type Ca2 + channel for the Ca2 +  
influx, and that of Na+/K+-ATPase for the Ca2 +  efflux. A real-time PCR 
analysis revealed that the mRNA expression of four mineralization-related 
genes was clearly increased after 3 days of culture with a B-supplemented 
culture medium. Using microarray analyses, five genes involved in cell 
proliferation and differentiation were up-regulated compared to the control 
group. Regarding the Ca2 + influx, in the nifedipine-pretreated group, the 
relative fluorescence intensity for one min after adding B solution did not 
increase compared with that for one min before addition. In the control group, 
the relative fluorescence intensity was significantly increased compared with 
the experimental group (P<0.05). Regarding the Ca2 + efflux, in the 
experimental group cultured in 0.1 mM of B-supplemented medium, the 
relative fluorescence intensity for 10-min after ouabain treatment revealed a 
significantly lower slope value compared with the control group (P<0.01). 
This is the first study to demonstrate the acceleration of Ca2 + flux by B 
supplementation in osteoblastic cells.  Cell membrane stability is related to 
the mechanism by which a very low concentration of B promotes the 
proliferation and differentiation of mammalian osteoblastic cells in vitro .    
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A previous report that boron (B) can improve bone mineralization in chicks 
with dietary deficiency [1] first  demonstrated that B is beneficial and 
essential for higher animals. Analyses of both human and animal data 
suggested that an acceptable safe range of B intake for adults could be 1-13 
mg/d [2]. Furthermore, B was identified as a nutritionally important element 
throughout the life cycle [3]. Dietary B may be beneficial for optimal calcium 
metabolism and, as a consequence, optimal bone metabolism [4, 5].  Boron 
supplementation in rats and chicks has been shown to increase bone strength,  
and may also play a role in improving arthritis,  plasma lipid profiles, and 
brain function [6]. Moreover, dietary B deprivation in mice has been shown 
to alter periodontal alveolar bone modeling and remodeling by inhibiting 
bone formation [7]. 
  Ca2 + signaling and homeostasis related to B supplementation or 
deprivation have been widely investigated in plants [8, 9] compared with 
mammals. The activity of Ca2 + channels,  pumps and transporters is 
responsible for generating the influx and efflux of Ca2 +,  which regulate its 
homeostasis.  Cyclic nucleotide-gated ion channels, autoinhibited Ca2 +-
ATPase and cation/H+ exchanger proteins are involved in this process [10-
12]. Furthermore, elevated intracellular Ca2 + has been reported to stimulate 
MAPK activity in several mammalian cell  lines [13-15]. 
  A very low concentration of B accelerates the proliferation and 
differentiation in mammalian osteoblastic cells in vitro [16, 17]. However, 
the mechanisms of these phenomena are stil l  not well understood. The aim of 
this study was to investigate the effects of B on the membrane function of 
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osteoblastic cells in vitro .  After the expression of calcification-related genes 
associated with Ca2 + metabolism in the hard tissue was analyzed using  real-
time PCR in osteoblastic cells under B supplementation, the genes involved 
in cell activity were investigated using gene expression microarray analyses. 
Finally, the Ca2 + influx and efflux were evaluated to demonstrate the 
activation of the L-type Ca2 + channel for the Ca2 + influx, and that of Na+/K+-
ATPase for the Ca2 +  efflux.  
 
Materials and Methods 
 
Cell  Culture for Passage 
 
Osteoblastic cells (NOS-1 cells [18]) derived from human osteosarcoma were 
used in the present study. They were seeded in a 60-mm culture dish at a 
density of 5×105 cells in α-MEM (Gibco, Palo Alto, CA, USA) supplemented 
with 10% fetal bovine serum (FBS) (MP Biomedicals, Santa Ana, CA, USA) 
and 0.01% penicillin-streptomycin (Life Technologies),  and then were 
cultured in a humidified incubator at 37oC in an atmosphere of 5% CO2 and 
air. The medium was changed every 3 days.  
 
Preparation of Boron Solution 
 
Boric acid was purchased from Wako (Osaka, Japan). A 100 mM solution of 
B was prepared by dissolving powdered boric acid in α-MEM without FBS. 
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The completely dissolved solution was fil tered using a 0.2 μm filter as a stock 
solution.  
 
Total RNA Isolation for Real-time PCR and Microarray 
 
NOS-1cells were seeded in a 60-mm culture dish at a density of 7×104 
cells/cm2 in α-MEM without FBS. A 0.1 mM B was used for all  experiments 
in this study, because our basic experiments indicated that a 0.1 mM of B 
was suitable for the proliferation of NOS-1 cells [19].  After 3 days of culture 
with or without a 0.1 mM of B, total RNA from cells were isolated using 
TRIzol reagent (1 mL/10cm2) (Invitrogen, Carlsbad, CA, USA), and purified 
using the SV Total RNA Isolation System (Promega, Madison, WI, USA) 
according to the manufacturer’s instructions.  
 
Real-time PCR for Mineralization-related Genes 
 
Real-time PCR was used to detect the expression of four mineralization-
related genes, alkaline phosphatase (ALP), osteopontin (OPN), osteocalcin 
(OCN), and bone sialoprotein (BSP). cDNA synthesis and amplification via 
PCR were performed using the SuperScript™ First-Strand Synthesis System 
(Invitrogen) and an oligo dT primer. cDNA obtained from 400 ng of total 
RNA was used for one PCR. For each real-time PCR sample, a master mix of 
the following reaction components was prepared at the indicated quantit ies: 
9.1 μl  of water, 0.3 μl  of diluted reference dye, 0.2 μl  of forward and reverse 
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primers (Table 1) and 10 μl  of Brilliant® SYBR® Green QPCR master mix 
(Stratagene, La Jolla, CA, USA). The above-mentioned reaction was placed 
in a 0.2 ml tube and 0.2 μl  of cDNA was added as the PCR template. The PCR 
sequence protocol was as follows: denaturation (94oC, 1 min) followed by 40 
cycles of amplification and quantification (56oC, 1 min) and a final extension 
(72oC, 1 min).  Amplification and data acquisition were performed using an 
Mx3000P QPCR machine (Stratagene).  
  Quantification was accomplished by determining the threshold cycle (the 
second derivative of the resulting fluorescence curve) at which the amplicon 
is detected during PCR and then comparing this to the standard curve 
calculated from the parallel quantification reactions. These calculations were 
performed with the comparative quantification method using the Stratagene 
form. These data were normalized by glyceraldehyde phosphate 
dehydrogenase (GAPDH). 
 
Gene Expression Microarray for Proliferation and Differentiation 
 
The cRNA was amplified, labeled using GeneChip® WT Terminal Labeling 
and Control Kit (Affymetrix, Santa Clara, CA, USA), and hybridized to an 
Affinity Human Genome U133 Plus 2.0 array (for 47,000 transcriptional 
products) according to the manufacturer’s instructions. All hybridized 
microarrays were scanned by an Affymetrix scanner. Relative hybridization 
intensities and background hybridization values were calculated using the 
Affymetrix Expression ConsoleTM. 
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Data Analysis and Filter Criteria 
 
The raw signal intensities for each probe were calculated from hybridization 
intensities. The raw signal intensities of two samples were log2-transformed 
and normalized by RMA and quantile algorithm [20] with Affymetrix® 
Expression Console™ 1.1 software. To identify up-regulated genes, Z-scores 
[21] from ratios (non-log scaled original fold-change) were calculated from 
the normalized signal intensities of each probe for comparison between 
control and experiment samples. Then, we established the criterion for the 
up-regulated genes (Z-score > 2.0). 
 
Real-time PCR after Microarray 
 
The NOS-1 cells were seeded and cultured under the same conditions as those 
in the experiment for calcification-related genes. The protocols for RNA 
extraction, cDNA synthesis,  and PCR were similar to the above-mentioned 
methods. Primer’s sequences of the target genes were listed in Table 2. 
 
Cell  Culture for Ca2 + Flux Studies 
 
In the Ca2+ influx study, the NOS-1 cells were cultured in a 35 mm glass-
bottom culture dish (FluoroDish, World Precision Instruments, Sarasota, FL, 
USA) at a density of 3×105  cells in α-MEM without FBS and B for 3 days. 
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For the L-type Ca2 + channel blocker-applied group, nifedipine  (final 
concentration of 10 μM) was added to α-MEM and cultured for 30 min before 
Fluo 4-AM loading. The control group was incubated in α-MEM containing 
solvent, ethanol at  a final concentration of 0.05%. In the Ca2 + efflux study, 
the NOS-1 cells were cultured in a 35 mm glass-bottom culture dish 
(FluoroDish) at a density of 6×105  cells in α-MEM without FBS for 3 days. 
In the Na+/K+-ATPase-activated group, B solution at a final concentration of 
0.1 mM was added to α-MEM. The control group was incubated in only α-
MEM.  
 
Fluo 4-AM Loading  
 
The cells were loaded with Fluo 4-AM (DOJINDO LABORATORIES, 
Kumamoto, Japan) by incubation with a low sodium HEPES assay buffer (5 
mM NaCl, 135 mM choline chloride, 10 mM HEPES, 5 mM KCl, 1 mM MgCl2, 
10 mM glucose),  0.5% Fluo 4-AM in DEMSO, 1.25 mM probenecid,  and 
0.04% Pluronic F-127 (BASF SE, Ludwigshafen, Germany) in a 5% CO2 
incubator for 15 min. 
 
Confocal Laser Microscopy 
 
In the Ca2 + influx experiment, Fluo 4-AM loaded cells in a 35 mm glass-
bottom culture dish were covered with 990 μL of recording buffer (115 mM 
NaCl, 20 mM HEPES, 5.4 mM KCl, 0.8 mM MgCl2,  1.8 mM CaCl2, 13.8 mM 
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glucose) and 1.25 mM probenecid for fluorescence observation of Ca2 + influx 
using a confocal laser microscope (TCS SL, Leica Microsystems GmbH, 
Wetzlar,  Germany). The approximate fluorescence excitation/emission 
maximum for imaging of intracellular Ca2 + was 495/518 nm. One min after 
setting on the microscopic stage, activation of the Ca2 + channel was 
investigated by adding 10 μL of B solution at a final concentration of 0.1 mM 
into the recording buffer. Fluorescence was scanned every 10 s and recorded 
on about 5-6 cells for a total of 1 min (n=3). The effect of B on the Ca2 + 
influx was examined by comparing the coefficient (slope) of a regression line 
calculated using the least-squares method in both the experimental and 
control groups. In the Ca2 + efflux experiment, Fluo 4-AM loading cells were 
incubated in a 5% CO2 microscopic stage incubator (H301-TC1-HMTC, 
Okolab S.r.L.,  NA, Italy) for 15 min with recording buffer (low sodium 
HEPES assay buffer,  1.25 mM probenecid, and 0.5 mM ouabain) for 
fluorescence observation of the Ca2 + efflux using a confocal laser microscope. 
Fluorescence was scanned every 10 s and recorded on about 20 cells for a 
total of 10 min (n=3). The comparison between the experimental and control 
groups was similarly analyzed using the method described in the Ca2 + influx 




The data were expressed as the means + standard deviation. The differences 
between the two groups were assessed using the one-tailed Student’s t-test.  
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Gene Expression for Mineralization 
 
The real-time PCR analysis revealed that the mRNA expression of four 
mineralization-related genes, ALP, OPN, OCN, and BSP, was clearly 
increased after 3 days of culture with 0.1 mM of boron-supplemented culture 
medium, with average balanced score ratios of 7.1, 8.4, 1.7, and 1.6, 
respectively, compared with the control groups (Fig. 1).  
 
Gene Expression for Proliferation and Differentiation 
 
Using a microarray analysis, 119 of the up-regulated genes (Z-score > 2.0) 
were confirmed. Among them, five genes craniofacial development protein 1 
(CFDP), stromal cell  derived factor 4 (SDF4), mitogen-activated protein 
kinase kinase 1 (MAP2K1), catenin alpha 1 isoform (CTNNA1), and collagen 
type I alpha 1 (COL1A1), involved in osteoblastic cell  proliferation and 
differentiation processes were furthermore compared with the control group 
using a real-time PCR (Table 3).  Although 96 of the down-regulated genes 
(Z-scores<-2) were confirmed, they were not found to be related to the 
osteoblastic cell  proliferation or differentiation processes. 
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The PCR analysis revealed that the mRNAs expression of CFDP, SDF4, 
MAP2K1, CTNNA1, and COL1A1 was clearly increased after 3 days of 
culture with 0.1 mM B, with average balanced score ratios of >1.3, compared 
with the control group (Fig. 2). 
 
Acceleration of the Ca2 + flux 
 
Regarding the Ca2 + influx, in the nifedipine-pretreated group, the relative 
fluorescence intensity for one min after the addition of 10 μL of B solution 
was not increased compared with that for one min before the addition of 10 
μL of B solution, and the calculated slope was judged to be zero, including 
negative values. In the control group, the relative fluorescence intensity for 
one min after addition of 10 μL of B solution increased compared with that 
for one min before the addition of 10 μL of B solution, and the calculated 
slope was 3 + 1.7 (Figs. 3 and 4). There was a significant difference between 
the experimental and control groups (P<0.05).  
  Regarding the Ca2 + efflux, in the experimental group cultured in 0.1 mM 
of B supplemented medium, the relative fluorescence intensity for 10-min 
after ouabain treatment revealed a significantly lower slope value (3.3 + 0.6) 





In the present study, NOS-1 cells accelerated the osteoblastic function after 
3-day culture in 0.1 mM of B supplemented medium, which was demonstrated 
by the increased expression of calcification-related genes. Bone ALP is an 
early stage marker essential  for osteoblast proliferation [22]. OPN, OCN, and 
BSP are frequently used as markers for osteoblast differentiation [22-24]. 
These scientific data indicated that the NOS-1 cell  line preserves osteoblastic 
cell  characteristics, and a low concentration of B directly stimulates both the 
proliferation and differentiation pathways in osteoblastic NOS-1 cells.  
  Microarray and real-time PCR analyses for detecting genes involved in 
proliferation and differentiation in NOS-1 cells revealed that the z-score data 
using standard deviations more clearly demonstrated the effect of B on NOS-
1 cells compared with the original ratio data. Five genes, including one of 
the intracellular signal transducer genes (MAPK), demonstrated increased 
gene expressions. To the best of our knowledge, this finding is the first to 
indicate that B stimulates the intracellular signal pathway through MAPKs. 
As the intimate relationship between intracellular Ca2 + and MAPKs has been 
already reported in several cell  l ines [13-15], we evaluated the effect of B on 
the intracellular Ca2+ flux to determine the mechanism by which B activates 
osteoblasts in this study. 
The L-type Ca2+ channel has reported to exist in the cell membrane of 
osteoblasts [25]. Osteoblast L-type Ca2 + channels are activated by numerous 
bone regulatory factors,  including parathyroid hormone [26-28], vitamin D3 
[27, 29, 30], mechanical stimuli [31, 32], ascorbic acid [33], and ALP [34].  
Whether B accelerates the L-type Ca2+ channel in osteoblasts has not yet been 
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determined. This is  the first report to identify the effect of B on the L-type 
Ca2 + channel in osteoblasts. For this purpose, nifedipine, a specific inhibitor 
of the L-type Ca channel,  was used in this study. Nifedipine slows Ca2+ entry 
into cardiac and smooth muscle cells by blocking the L-type Ca2+ channel,  
thereby disrupting the excitation and contraction processes [35, 36]. Ca2 + 
channel blockers prevent Ca2 + influx, and promote osteoblastic 
differentiation through high membrane retaining ability [37].  In the present 
study, although B significantly promoted the Ca2 + influx in NOS-1 cells pre-
treated without nifedipine, it  did not accelerate the Ca2+ influx in NOS-1 cell  
pre-treated with nifedipine. These findings demonstrate that the L-type Ca2 + 
channel exists in the NOS-1 cell membrane, and a low concentration of B 
rapidly stimulates this channel.  This B effect on osteoblastic activity most 
likely promotes cell membrane stability.  
  According to the effect of B on cell membrane activity, the Ca2+ efflux 
was evaluated as osteoblastic cells promote calcification. Ouabain (cardiac 
glycoside),  a commonly used inhibitor of Na+/K+-ATPase, was used to 
investigate the effect of B. This enzyme catalyzes the coupled active 
transport of Na+ and K+ across the plasma membrane as a sodium pump [38, 
39].  The effect of ouabain is due to the partial inhibit ion of Na+/K+-ATPase, 
which causes an increase in intracellular Na+, which in turn affects the 
sarcolemmal Na+/Ca2 + exchanger and leads to the increase in intracellular 
Ca2 + as the cause of positive inotropic action [40, 41]. Our study is also the 
first to identify the effect of B on Na+/K+-ATPase activity in osteoblasts . In 
the present study, Ca2 + fluorescence intensity in NOS-1 cells cultured with 
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0.1 mM B supplemented medium was significantly lower than that without B. 
B suppressed the effect of ouabain. These findings clearly demonstrate that 
NOS-1 cells contains Na+/K+-ATPase in their cell membranes, and B 




To the best of our knowledge, this is the first report to demonstrate the 
acceleration of the Ca2 + influx and efflux by B supplementation in cultured 
osteoblastic cells.  Moreover, the membrane stabilizing activity of B was 
addressed by our findings. Cell membrane stability may be related to the 
mechanism by which a very low concentration of B promotes the proliferation 
and differentiation in mammalian osteoblastic cells in vitro.   
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Fig. 1 Real-time PCR reactions for 4 mineralization-related genes, ALP, OPN, 
OCN, and BSP. Each bar represents the standard deviation of triplicate 
samples. 
Fig. 2 Real-time PCR reactions for 5 genes related to proliferation and 
differentiation, CFDP1, SDF4, MAP2K1, CTNNA1, and COL1A1. Each bar 
represents the standard deviation of triplicate samples. 
Fig. 3 A typical example of the Ca2 + influx after pretreatment with nifedipine 
in the experimental group. (a) Fluo 4-AM fluorescence from the cells,  1 min 
before B supplementation [red arrow in (d)].  (b) Fluorescence from the same 
cells,  0 min after B supplementation [yellow arrow in (d)]. (c)  Fluorescence 
from the same cells,  1 min after B supplementation [green arrow in (d)].  Scale 
bar = 20 μm. (d) The curve of fluorescent signal intensity with time 
(calculated slope after B supplementation: 0).  
Fig. 4 A typical example of the Ca2 + influx without pretreatment of nifedipine 
(control group). (a) Fluo 4-AM fluorescence from the cells,  1 min before B 
supplementation [red arrow in (d)].  (b) Fluorescence from the same cells 0 
min after B supplementation [yellow arrow in (d)].  (c) Fluorescence from the 
same cells,  1 min after B supplementation [green arrow in (d)]. Scale bar = 
20 μm. (d) The curve of fluorescent signal intensity with time (calculated 
slope after B supplementation: 2). 
Fig. 5 A typical example of the Ca2 + efflux after culture with B in the 
experimental group. (a) Fluo 4-AM fluorescence from the cells,  0 min after 
ouabain pretreatment.  (b) Fluorescence from same cells after 10 min. Scale 
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bar = 20 μm. (c) The curve of fluorescent signal intensity with time 
(calculated slope for 10 min: 3).  
Fig. 6 A typical example of the Ca2 + efflux after culture without B in the 
control group. (a) Fluo 4-AM fluorescence from the cells,  0 min after ouabain 
pretreatment. (b) Fluorescence from the same cells after 10 min. Scale bar = 
20 μm. (c) The curve of fluorescent signal intensity with time (calculated 
slope for 10 min: 5).  
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